MILFORD — Rentschler Biopharma has announced another leadership change at its Milford-based U.S. headquarters.
The German biopharmaceutical company says Veit Bergendahl will step in as Chief Operating Officer on April 1. In the role, Bergendahl will oversee Rentschler’s clinical and commercial manufacturing operations, as well as engineering, technology, and automation production.
He replaces Benedikt von Braunmuehl, who stepped down last month. The company has also confirmed that Chief Operating Officer Christiane Bardroff will be leaving this spring. Her successor has not yet been announced.
Rentschler Biopharma operates globally, with its U.S. headquarters serving as a key hub for its manufacturing and development operations.
